News | EstVCA

Latest news Rss

Superangel's portfolio company Better Medicine received a €2.5 million grant from the European Innovation Council’s Accelerator.

Thanks to cutting-edge research at the Institute of Computer Science, Better Medicine, a Superangel's portfolio company that automates the analysis of cancer CT scans, has received a boost. Better Medicine was recently awarded with a €2.5 million grant from the European Innovation Council’s Accelerator.

Nordic Secondary Fund II has acquired an additional stake in Kilo.Health

Nordic Secondary Fund II has acquired an additional stake in Kilo.Health, which is the largest secondary deal of the fund so far - €9M of which €4M was invested in June last year and now another €5M was added to the investment.

EXIT: BaltCap sells Blue Bridge Technologies to Everfield

11 November 2022

BaltCap Latvia Venture Capital Fund (BLVCF) sells Blue Bridge Technologies, the leading provider of medical practice management systems in Latvia, to Everfield, a specialized software investor backed by private investment firm Aquiline Capital Partners.

SmartCap announced the application terms for SmartCap Greentech Investment Programme

01 November 2022

SmartCap announced the Greentech Investment Programme for greentech startup companies to apply for an investment from SmartCap Green Fund. SmartCap aims to invest up to 20 million into direct equity or convertible instruments.

Siena Secondary Fund acquires a stake in Kry, Europe's leading e-health start-up

09 February 2022

Siena Secondary Fund, which focuses on secondary transactions in fast growing late stage startups providing liquidity to early stage investors, employees and founders, completed its first transaction outside the Baltics with the acquisition of Kry International AB, Europe's leading eHealth start-up. (“Kry”).

Karma Ventures’ portfolio company Infermedica raises $30M Series B round investment

26 January 2022

The round was led by One Peak and included participation from previous investors Karma Ventures, European Bank for Reconstruction and Development, Heal Capital and Inovo Venture Partners.

DEAL TALKS: Martin Kõdar and Oliver Kullman of BaltCap talk about funds´ exit from Qvalitas and Unimed

Our member BaltCap recently announced selling Qvalitas Arstikeskus and Unimed Grupp to Mehiläinen. EstVCA DEAL TALKS had a chat BaltCap partners Martin Kõdar and Oliver Kullman to hear a bit more about the exit.

EXIT: BaltCap sells Qvalitas and Unimed to leading Nordic healthcare company Mehiläinen

BaltCap Private Equity Fund II (BPEF II) sells the Estonian private healthcare companies – occupational healthcare provider Qvalitas Arstikeskus and dental care chain Unimed Grupp – to Mehiläinen, the leading private provider of health care and social services in Finland.